JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 11 1830-1835
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Passchier, J.
Right arrow Articles by Vaalburg, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Passchier, J.
Right arrow Articles by Vaalburg, W.

In Vivo Delineation of 5-HT1A Receptors in Human Brain with [18F]MPPF

Jan Passchier, Aren van Waarde, Remge M. Pieterman, Philip H. Elsinga, Jan Pruim, Harry N. Hendrikse, Antoon T.M. Willemsen and Willem Vaalburg

PET Center, Groningen University Hospital, Groningen; Groningen University Institute for Drug Exploration, Groningen, The Netherlands

Serotonin-1A (5-hydroxytryptamine-1A [5-HT1A]) receptors have been reported to play an important role in the pathophysiology of a variety of psychiatric and neurodegenerative disorders. Animal experiments have shown that 4-(2'-methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine ([18F]MPPF) may be suitable for 5-HT1A receptor imaging in humans. The aim of this study was to determine if [18F]MPPF can be used for the quantitative analysis of 5-HT1A receptor densities in brain regions of healthy human volunteers. Methods: [15O]H2O perfusion scanning was performed before intravenous injection of [18F]MPPF to obtain anatomic information. Cerebral radioactivity was monitored using a PET camera. Plasma metabolites of [18F]MPPF were determined by high-performance liquid chromatography. Binding potentials were calculated using the metabolite-corrected arterial input function and a linear graphic method (Logan-Patlak analysis). Results: The highest levels of radioactivity were observed in the medial temporal cortex, especially in the hippocampal area. In contrast, the cerebellum and basal ganglia showed low uptake of 18F, in accordance with known 5-HT1A receptor distribution. The calculated binding potentials correlated well with literature values for 5-HT1A receptor densities. The binding potentials for [18F]MPPF were 4–6 times lower than those that have been reported for [carbonyl-11C]-(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl) cyclohexanecarboxamide (WAY 100635), indicating that [18F]MPPF has a lower in vivo affinity for 5-HT1A receptors. Conclusion: These results confirm that [18F]MPPF can be used for the quantitative analysis of 5-HT1A receptor distribution in the living human brain. The rapid dissociation from the receptor makes this ligand a possible candidate to monitor changes in endogenous serotonin levels.

Key Words: human • brain • serotonin-1A receptors • 5-hydroxytryptamine-1A receptors • 4-(2'-methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]ethylpiperazine

Received Oct. 12, 1999; revision accepted Mar. 28, 2000.

For correspondence or reprints contact: Jan Passchier, PhD, PET Center, Groningen University Hospital, 9700 RB Groningen, The Netherlands.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
C. A. Shively, D. P. Friedman, H. D. Gage, M. C. Bounds, C. Brown-Proctor, J. B. Blair, J. A. Henderson, M. A. Smith, and N. Buchheimer
Behavioral Depression and Positron Emission Tomography-Determined Serotonin 1A Receptor Binding Potential in Cynomolgus Monkeys.
Arch Gen Psychiatry, April 1, 2006; 63(4): 396 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Riad, L. Zimmer, L. Rbah, K. C. Watkins, M. Hamon, and L. Descarries
Acute Treatment with the Antidepressant Fluoxetine Internalizes 5-HT1A Autoreceptors and Reduces the In Vivo Binding of the PET Radioligand [18F]MPPF in the Nucleus Raphe Dorsalis of Rat
J. Neurosci., June 9, 2004; 24(23): 5420 - 5426.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. Zimmer, L. Rbah, F. Giacomelli, D. Le Bars, and B. Renaud
A Reduced Extracellular Serotonin Level Increases the 5-HT1A PET Ligand 18F-MPPF Binding in the Rat Hippocampus
J. Nucl. Med., September 1, 2003; 44(9): 1495 - 1501.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Passchier, A. van Waarde, W. Vaalburg, and A. T.M. Willemsen
On the Quantification of [18F]MPPF Binding to 5-HT1A Receptors in the Human Brain
J. Nucl. Med., July 1, 2001; 42(7): 1025 - 1031.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.